Joint association of plasma ceramide and renal function with coronary artery lesion severity: The CRUISE-MET study
Journal of Clinical Lipidology · 2025-11 · 19 (6) · 1586-1597
DOI: 10.1016/j.jacl.2025.09.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2025-11. Verfasst von Qiang Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (Drs Chen, Li, …. Hauptthemen laut MEDLINE: Ceramides, Coronary Artery Disease, Kidney, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Ceramides and chronic kidney disease (CKD) independently promote atherosclerosis, yet their synergistic effect remains underexplored. This study systematically investigates their combined impact on coronary lesion severity. METHOD: This cross-sectional analysis included coronary artery disease (CAD) patients from the CRUISE-MET trial (NCT06383208). Six ceramide species: Cer (18:1/16:0), Cer (18:1/18:0), Cer (18:1/20:0), Cer (18:1/22:0), Cer (18:1/24:0), and Cer (18:1/24:1), were quantified via ultra-high performance liquid chromatography-mass spectrometry/mass spectrometry. Baseline SYNTAX score (bSS) > 22 defined complex CAD. CKD was classified based on both estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR). The combined and mediating effects of ceramides and renal dysfunction on coronary lesion complexity were further evaluated. RESULT: Among 691 CAD patients, those with complex lesions exhibited elevated UACR, Cer (18:1/16:0), Cer (18:1/18:0), Cer (18:1/24:1), and decreased eGFR (all P median), with combined exposure increasing complex CAD risk 4.4-fold (OR = 4.40, 95% CI: 2.74-7.07; P < .001). Mediation analysis implicated renal impairment in 28.1% (UACR) and 13.9% (eGFR) of ceramide's atherogenic effects. Sensitivity analyses confirmed robustness in diabetic and hypertensive subgroups. CONCLUSION: The study highlights ceramide-renal synergy in exacerbating coronary atherosclerosis, advocating integrated biomarker profiling for risk stratification and dual-targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (Drs Chen, Li, He, Xie, Yang, Zhou, and Zheng); Department of Cardiology, China-Japan…
- Department of Cardiology, China-Japan Friendship Hospital, Beijing, China (Drs Chen, Li, He, Xie, D. Fu, Gao, Li, S. Fu, Mu, Sun, Yang, Zhou, Li, Gao, and Zheng).
- Department of Cardiology, China-Japan Friendship Hospital, Beijing, China (Drs Chen, Li, He, Xie, D. Fu, Gao, Li, S. Fu, Mu, Sun, Yang, Zhou, Li, Gao, and Zheng); Department of Cardiology, Peking University China-Japan…
- Department of Cardiology, China-Japan Friendship Hospital, Beijing, China (Drs Chen, Li, He, Xie, D. Fu, Gao, Li, S. Fu, Mu, Sun, Yang, Zhou, Li, Gao, and Zheng); China-Japan Friendship Clinical Medical College, Beijing…
- Department of Cardiology, China-Japan Friendship Hospital, Beijing, China (Drs Chen, Li, He, Xie, D. Fu, Gao, Li, S. Fu, Mu, Sun, Yang, Zhou, Li, Gao, and Zheng). Electronic address: gaoyx1980@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, Q., Li, Y., He, H., Xie, Y., Fu, D., Gao, R., Li, N., Fu, S., Mu, Y., Sun, Y., Yang, Z., Zhou, J., Li, X., Gao, Y., & Zheng, J. (2025). Joint association of plasma ceramide and renal function with coronary artery lesion severity: The CRUISE-MET study. Journal of Clinical Lipidology, 19(6), 1586-1597. https://doi.org/10.1016/j.jacl.2025.09.002
Vancouver
Chen Q, Li Y, He H, Xie Y, Fu D, Gao R, et al. Joint association of plasma ceramide and renal function with coronary artery lesion severity: The CRUISE-MET study. Journal of Clinical Lipidology. 2025;19(6):1586-1597. doi:10.1016/j.jacl.2025.09.002
BibTeX
@article{Chen2025,
author = {Chen, Qiang and Li, Yike and He, Haoming and Xie, Yingying and Fu, Dongliang and Gao, Ruilong and Li, Nan and Fu, Sunjin and Mu, Yakun and Sun, Yuxuan and Yang, Zixuan and Zhou, Jiahui and Li, Xu and Gao, Yanxiang and Zheng, Jingang},
title = {Joint association of plasma ceramide and renal function with coronary artery lesion severity: The CRUISE-MET study},
journal = {Journal of Clinical Lipidology},
year = {2025},
volume = {19},
number = {6},
pages = {1586--1597},
doi = {10.1016/j.jacl.2025.09.002}
}
EUVIMED